Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits.
Recent data from our laboratory have indicated that the rabbit is a suitable animal model for the study of enzyme activities of the tryptophan-nicotinic acid pathway. We report here the pattern of tryptophan metabolism in rabbits made diabetic with alloxan treatment, and hypercholesterolemic with a high-cholesterol diet. A group of rabbits with only hypercholesterolemia was also considered. The enzymes assayed were: liver tryptophan 2,3-dioxygenase (TDO), intestine indoleamine 2,3-dioxygenase (IDO), liver and kidney kynurenine 3-monooxygenase, kynurenine-oxoglutarate transaminase, kynureninase, 3-hydroxyanthranilate 3,4-dioxygenase and aminocarboxymuconate-semialdehyde decarboxylase.TDO showed a reduction of specific activity in liver of diabetic-hyperlipidemic and hyperlipidemic rabbits compared to controls. Intestine IDO activities and liver and kidney kynurenine monooxygenase were unchanged with respect to controls.Kynurenine-oxoglutarate transaminase and kynureninase activities were reduced in the kidneys, but not in the liver, of diabetic-hyperlipidemic rabbits. The main finding was the reduction of 3-hydroxyanthranilate 3,4-dioxygenase activity (expressed as activity per g of fresh tissue) in the liver and kidneys of diabetic-hypercholesterolemic and hyperlipidemic rabbits compared to controls. Conversely, aminocarboxymuconate-semialdehyde decarboxylase activity was significantly higher in diabetic hypercholesterolemic rabbits in comparison with control and hypercholesterolemic rabbits. These data demonstrate that also in diabetic rabbits there is an alteration of tryptophan metabolism at the level of 3-hydroxyanthranilic acid-->nicotinic acid step. Also dyslipidemia seems to be involved in enzyme activity variations of the tryptophan metabolism along the kynurenine pathway.
Ragazzi
Eugenio
E
Department of Pharmacology, University of Padova, Largo E. Meneghetti 2, Padua, Italy.
Costa
Carlo V L
CV
Caparrotta
Laura
L
Biasiolo
Monica
M
Bertazzo
Antonella
A
Allegri
Graziella
G
D050561:3-Hydroxyanthranilate 3,4-Dioxygenase; D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000201:enzymology / Q000378:metabolism*; D049308:Dioxygenases; D006949:Hyperlipidemias / Q000378:metabolism; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D007668:Kidney / Q000201:enzymology; D007737:Kynurenine / Q000096:biosynthesis; D050601:Kynurenine 3-Monooxygenase; D008099:Liver / Q000201:enzymology; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009525:Niacin / Q000378:metabolism; D010105:Oxygenases / Q000378:metabolism; D011817:Rabbits; D014364:Tryptophan / Q000378:metabolism*; D014366:Tryptophan Oxygenase / Q000378:metabolism
D002791:Cholesterol, Dietary; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D009525:Niacin; D007737:Kynurenine; D014364:Tryptophan; D006899:Mixed Function Oxygenases; D010105:Oxygenases; D049308:Dioxygenases; D014366:Tryptophan Oxygenase; D050561:3-Hydroxyanthranilate 3,4-Dioxygenase; D050601:Kynurenine 3-Monooxygenase; D002262:Carboxy-Lyases; C024396:aminocarboxymuconate-semialdehyde decarboxylase